Form 4: Vita Coco Company Executive Charles van Es Executes Stock Options and Sells Shares Under 10b5-1 Plan
SEC Form 4
Charles van Es, Chief Sales Officer of Vita Coco Company, exercised stock options and sold 9,500 shares of common stock at an average price of $31.029 per share on October 30, 2024, pursuant to a pre-arranged Rule 10b5-1 trading plan.
Summary
- On October 30, 2024, Charles van Es, the Chief Sales Officer of Vita Coco Company, exercised non-qualified stock options to acquire 9,500 shares of common stock at a price of $10.178 per share.
- Simultaneously, van Es sold 9,500 shares of common stock at a weighted average price of $31.029 per share, with individual transactions ranging from $31.00 to $31.20.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan.
- Following these transactions, van Es directly owns 97,668 shares of Vita Coco Company common stock.
- Van Es also holds various non-qualified stock options for a total of 264,224 shares at exercise prices ranging from $10.178 to $26.18, vesting at various dates.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The document simply reports insider trading activity under a pre-arranged plan. There are no explicit positive or negative indicators about the company's performance.
Positives
- The exercise of stock options demonstrates van Es's belief in the company's long-term value.
- The Rule 10b5-1 trading plan provides transparency and avoids concerns about insider trading.
Negatives
- The sale of shares, even under a 10b5-1 plan, could be perceived negatively by some investors.
Risks
- Future stock sales by insiders could put downward pressure on the stock price.
- Changes in the company's performance or market conditions could affect the value of the remaining stock options.
Future Outlook
The document does not contain specific forward-looking statements regarding the company's future performance.
Industry Context
Insider transactions are common in publicly traded companies and are closely monitored by investors and regulators. Rule 10b5-1 plans are frequently used to allow insiders to sell shares without raising concerns about insider trading.
Comparison to Industry Standards
- Comparing the Vita Coco Company to similar beverage companies like National Beverage Corp. (FIZZ) or Keurig Dr Pepper (KDP), insider trading activity is a normal part of executive compensation.
- The use of 10b5-1 plans is a common practice among executives in publicly traded companies to manage their stock holdings in a compliant manner, similar to practices seen at companies like Coca-Cola (KO) and PepsiCo (PEP).
Stakeholder Impact
- The transactions could have a minor impact on shareholders, depending on their perception of insider selling.
- The use of a 10b5-1 plan ensures transparency and reduces potential negative sentiment.
Key Dates
| Date | Description |
|---|---|
| October 1, 2024 | Date of Power of Attorney execution. |
| October 30, 2024 | Date of stock option exercise and share sale. |
| November 1, 2024 | Date of signature on the Form 4 filing. |
| December 16, 2029 | Expiration date of one of the non-qualified stock option grants. |
| February 10, 2030 | Expiration date of one of the non-qualified stock option grants. |
| January 11, 2031 | Expiration date of one of the non-qualified stock option grants. |
| October 21, 2031 | Expiration date of one of the non-qualified stock option grants. |
| August 15, 2032 | Expiration date of one of the non-qualified stock option grants. |
| March 10, 2033 | Expiration date of one of the non-qualified stock option grants. |
| March 4, 2034 | Expiration date of one of the non-qualified stock option grants. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.